Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Sorting protein in neurons protects against neurodegenerative disorders

Like a sorting machine in an assembly line, a molecule known as VPS35 detects and removes defective proteins from neurons.

10 Jul 2019

$4.23 million NIH grant to support development of Cleveland Alzheimer's Disease Research Center

The National Institute on Aging of the National Institutes of Health awarded a $4.23 million grant to establish the Cleveland Alzheimer's Disease Research Center.

10 Jul 2019

Age-related risk of Alzheimer's explained at the molecular level

Studies have shown that Alzheimer’s disease (AD) incidence increases with age. This association with age also correlates with deposits of abnormal tau protein in the brain found a new study.

9 Jul 2019

Could hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?

Men who take hormone-blocking therapy (ADT) for prostate cancer may be at an increased risk of developing dementia and Alzheimer’s disease.

8 Jul 2019

Study sheds light on complex caspase-1-induced cell death mechanisms

Most unnecessary or dangerous cells such as virus-infected cells commit suicide by activating an in-built suicide program.

5 Jul 2019

Advances in artificial intelligence could shed light on aging process

There are two kinds of age: chronological age, w hich is the number of years one has lived, and biological age, which is influenced by our genes, lifestyle, behavior, the environment and other factors.

4 Jul 2019

OU Health Sciences Center awarded federal grant to enhance dementia care across Oklahoma

The University of Oklahoma Health Sciences Center, working with partners across the state, has been awarded a $3.75 million federal grant to enhance the care and support of a growing group of Oklahomans - those who suffer from memory loss, Alzheimer's disease and other types of dementia.

3 Jul 2019

Study: Biomarkers in the blood may help predict recovery time after concussion

A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 Jul 2019

Dundee and Bukwang Pharm announce partnership to develop new drug for Parkinson's

The University of Dundee's Drug Discovery Unit has announced a multi-million-pound partnership with Korea-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson's disease.

3 Jul 2019

A non-coding RNA may play major role in memory formation

You could call this a neat discovery. Researchers at the University of Alabama at Birmingham have found that a tissue-specific, non-coding RNA called NEAT1 has a major, previously undescribed role in memory formation.

3 Jul 2019

Using popular anticonvulsant drug to thwart inflammation

Serious conditions, including sepsis, stem from inflammation in the body, and there is a lack of effective medication for sepsis.

2 Jul 2019

Researchers explore connection between sense of smell, pollution and neurological disease

A consensus is building that air pollution can cause neurological diseases such as Alzheimer's disease and Parkinson's disease, but how fine, sooty particles cause problems in the brain is still an unanswered question.

2 Jul 2019

UK charity invests £1 million to develop potential therapeutic for Parkinson's

Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.

1 Jul 2019

Use of statins linked to reduction of mortality risk in dementia patients

The use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Academy of Neurology Congress has shown.

1 Jul 2019

Interdisciplinary workgroup outlines what is known and unknown about paradoxical lucidity

It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.

29 Jun 2019